JP Morgan Chase’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56K Sell
2,604
-73
-3% -$1.9K ﹤0.01% 6149
2025
Q4
$56.2K Buy
2,677
+136
+5% +$1.43K ﹤0.01% 6179
2025
Q3
$25.3K Sell
2,541
-339
-12% -$3.83K ﹤0.01% 6422
2025
Q2
$26.1K Sell
2,880
-175
-6% -$1.67K ﹤0.01% 6111
2025
Q1
$29.1K Sell
3,055
-4,006
-57% -$48.6K ﹤0.01% 6038
2024
Q4
$79.3K Buy
7,061
+4,465
+172% +$59.8K ﹤0.01% 5838
2024
Q3
$37.3K Buy
2,596
+48
+2% +$711 ﹤0.01% 6081
2024
Q2
$44K Sell
2,548
-3,124
-55% -$45.6K ﹤0.01% 5905
2024
Q1
$113K Buy
5,672
+94
+2% +$1.16K ﹤0.01% 5620
2023
Q4
$58.7K Buy
5,578
+5,574
+139,350% +$55.9K ﹤0.01% 5951
2023
Q3
$35 Hold
4
﹤0.01% 7058
2023
Q2
$39 Hold
4
﹤0.01% 6757
2023
Q1
$0 Hold
4
﹤0.01% 6906
2022
Q4
$0 Hold
4
﹤0.01% 6717
2022
Q3
$0 Hold
4
﹤0.01% 6599
2022
Q2
$0 Sell
4
-1,918
-100% -$22K ﹤0.01% 6625
2022
Q1
$38K Buy
1,922
+366
+24% +$7.4K ﹤0.01% 5898
2021
Q4
$38K Sell
1,556
-206
-12% -$6.89K ﹤0.01% 6033
2021
Q3
$69K Sell
1,762
-3,027
-63% -$126K ﹤0.01% 5731
2021
Q2
$216K Buy
+4,789
New +$181K ﹤0.01% 5205

Other funds holding GLSI

JP Morgan Chase's GLSI Position: Q1 2026 in Review

JP Morgan Chase reduced its Greenwich LifeSciences (GLSI) stake by 2.7% in Q1 2026, selling an estimated $1.9K and leaving 2,604 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #6149.

JP Morgan Chase first reported a position in GLSI in Q2 2021 and has held it in 20 quarters since. The position peaked at $216K in Q2 2021. 64 funds tracked by Wall St. Rank hold GLSI as of Q1 2026.

  • JP Morgan Chase held 2,604 shares of Greenwich LifeSciences worth $56K as of Q1 2026.
  • JP Morgan Chase sold 73 Greenwich LifeSciences shares in Q1 2026, an estimated $1.9K.
  • Greenwich LifeSciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6149 holding.
  • JP Morgan Chase first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's Greenwich LifeSciences position peaked at $216K in Q2 2021.
  • 64 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.